Key result
Elevated aldosterone-to-renin ratio and low renin linked to up to ~16% steeper eGFR decline.
Why the study?
Milder forms of renin-independent aldosterone production (subclinical primary aldosteronism) are highly prevalent, but their link with eGFR decline remains unknown.
Is subclinical primary aldosteronism (elevated ARR and suppressed renin) associated with steeper eGFR decline over time in adults with predominantly normal blood pressure?
Is subclinical primary aldosteronism (elevated ARR and suppressed renin) associated with steeper eGFR decline over time in adults with predominantly normal blood pressure?
Subclinical primary aldosteronism, characterized by elevated ARR and suppressed renin, is associated with a steeper decline in kidney function over time, independent of blood pressure.
Answers are grounded in this paper and cite their sources.
Does not support practice change; hypothesis-generating for aldosterone-targeted interventions to slow eGFR decline.
Background: Primary aldosteronism, an overt form of renin-independent aldosterone production, leads to steeper eGFR decline compared to primary hypertension. Mounting evidence suggests that milder forms of renin-independent aldosterone production (“subclinical primary aldosteronism”) are highly prevalent; however, the link between subclinical primary aldosteronism and eGFR decline remains unknown. Methods: This prospective cohort study included 976 Canadian adults aged 40-69 years, with predominantly normal blood pressure or mild untreated hypertension, from the randomly sampled, population-based CARTaGENE cohort. Aldosterone and renin concentrations were measured at enrollment (2009-2010). Creatinine and cystatin C were measured at enrollment and 5-7 years post-enrollment. Multivariable linear mixed regression models were used to measure the associations of aldosterone, renin, and the aldosterone-to-renin ratio (ARR) with eGFR decline over time. Results: The mean (SD) age of participants was 53 (7) years; 51% were female. Mean blood pressure was 121 (15)/72 (10) mmHg, and 11% had blood pressure ≥140/90 mmHg. Mean eGFRCrCysC was 109 (16) mL/min/1.73m2. At higher ARR levels, there was steeper mean eGFR decline over time [Tertile 1 (ARR ≤0.49 ng/dL per mU/L): -1.40 (1.77) mL/min/1.73m2/year, Tertile 2 (ARR 0.50-0.87 ng/dL per mU/L): -1.48 (1.75) mL/min/1.73m2/year, Tertile 3 (ARR >0.87 ng/dL per mU/L): -1.57 (1.79) mL/min/1.73m2/year; p=0.01], representing 11% steeper decline in the highest versus lowest ARR tertile. At lower renin levels, there was steeper mean eGFR decline over time [Tertile 1 (renin ≤9.2 mU/L): -1.59 (1.80) mL/min/1.73m2/year, Tertile 2 (renin 9.3-15.9 mU/L): -1.53 (1.77) mL/min/1.73m2/year, Tertile 3 (renin >15.9 mU/L): -1.33 (1.72) mL/min/1.73m2/year; p=0.04], representing 16% steeper eGFR decline in the lowest versus highest renin tertile. There was no significant association between aldosterone and eGFR change over time (p=0.50). All aforementioned associations were independent of blood pressure and were consistent among participants with normal blood pressure in isolation. Conclusions: Independent of blood pressure, elevated ARR and suppressed renin were associated with steeper eGFR decline over time.
No takes yet. Share an insight, caveat, or question.
Hundemer et al. (2026) studied this question. Elevated aldosterone-to-renin ratio and low renin levels were independently associated with 11-16% steeper eGFR decline over 5-7 years in adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: